Affiliation:
1. Bionanophotonic Systems Laboratory Institute of Bioengineering School of Engineering École Polytechnique Fédérale de Lausanne Lausanne 1015 Switzerland
2. Laboratory of Stem Cell Bioengineering Institute of Bioengineering School of Life Sciences and School of Engineering École Polytechnique Fédérale de Lausanne Lausanne 1015 Switzerland
3. Department of Oncology Centre Hospitalier Universitaire Vaudois Rue du Bugnon 46 Lausanne 1005 Switzerland
4. Ludwig Institute for Cancer Research Ludwig Lausanne Branch Chem. des Boveresses 155 Epalinges 1066 Switzerland
5. Swiss Cancer Center Leman Rue du Bugnon 25A Lausanne 1011 Switzerland
6. Agora Translational Research Center Rue du Bugnon 25A Lausanne 1011 Switzerland
Abstract
AbstractOrganoid tumor models have emerged as a powerful tool in the fields of biology and medicine as such 3D structures grown from tumor cells recapitulate better tumor characteristics, making these tumoroids unique for personalized cancer research. Assessment of their functional behavior, particularly protein secretion, is of significant importance to provide comprehensive insights. Here, a label‐free spectroscopic imaging platform is presented with advanced integrated optofluidic nanoplasmonic biosensor that enables real‐time secretion analysis from single tumoroids. A novel two‐layer microwell design isolates tumoroids, preventing signal interference, and the microarray configuration allows concurrent analysis of multiple tumoroids. The dual imaging capability combining time‐lapse plasmonic spectroscopy and bright‐field microscopy facilitates simultaneous observation of secretion dynamics, motility, and morphology. The integrated biosensor is demonstrated with colorectal tumoroids derived from both cell lines and patient samples to investigate their vascular endothelial growth factor A (VEGF‐A) secretion, growth, and movement under various conditions, including normoxia, hypoxia, and drug treatment. This platform, by offering a label‐free approach with nanophotonics to monitor tumoroids, can pave the way for new applications in fundamental biological studies, drug screening, and the development of therapies.